164 related articles for article (PubMed ID: 37852567)
1. Transthyretin Cardiac Amyloidosis Disguised as Light Chain Amyloidosis or Multiple Myeloma?
Stein AP; Matthia EL; Petty SA; Stewart B; Vilaro JR; Al-Ani MAZ; Ahmed MM; Aranda JM; Hiemenz JW; Parker AM
Am J Cardiol; 2024 Jan; 210():85-92. PubMed ID: 37852567
[TBL] [Abstract][Full Text] [Related]
2. Amyloid transthyretin cardiac amyloidosis with different manifestations, test findings and types.
Budweg J; Al-Ani M; Assaf Y; Parker A; Aranda J
BMJ Case Rep; 2023 Apr; 16(4):. PubMed ID: 37080632
[TBL] [Abstract][Full Text] [Related]
3. Sporadic Cardiac Amyloidosis by Amyloidogenic Transthyretin V122I Variant.
Nehashi T; Oikawa M; Amami K; Kanno Y; Yokokawa T; Misaka T; Yamada S; Kunii H; Nakazato K; Ishida T; Takeishi Y
Int Heart J; 2019 Nov; 60(6):1441-1443. PubMed ID: 31666456
[TBL] [Abstract][Full Text] [Related]
4. Practical recommendations for the diagnosis and management of transthyretin cardiac amyloidosis.
Bistola V; Parissis J; Foukarakis E; Valsamaki PN; Anastasakis A; Koutsis G; Efthimiadis G; Kastritis E
Heart Fail Rev; 2021 Jul; 26(4):861-879. PubMed ID: 33452596
[TBL] [Abstract][Full Text] [Related]
5. Genetic testing improves identification of transthyretin amyloid (ATTR) subtype in cardiac amyloidosis.
Brown EE; Lee YZJ; Halushka MK; Steenbergen C; Johnson NM; Almansa J; Tedford RJ; Cingolani O; Russell SD; Sharma K; Judge DP
Amyloid; 2017 Jun; 24(2):92-95. PubMed ID: 28494620
[TBL] [Abstract][Full Text] [Related]
6. Advances in the diagnosis and treatment of transthyretin amyloidosis with cardiac involvement.
Rigopoulos AG; Ali M; Abate E; Torky AR; Matiakis M; Mammadov M; Melnyk H; Vogt A; de Vecchis R; Bigalke B; Wohlgemuth W; Mavrogeni S; Noutsias M
Heart Fail Rev; 2019 Jul; 24(4):521-533. PubMed ID: 30790171
[TBL] [Abstract][Full Text] [Related]
7. Histological Typing in Patients With Cardiac Amyloidosis: JACC Review Topic of the Week.
Gonzalez-Lopez E; McPhail ED; Salas-Anton C; Dominguez F; Gertz MA; Dispenzieri A; Dasari S; Milani P; Verga L; Grogan M; Palladini G; Garcia-Pavia P
J Am Coll Cardiol; 2024 Mar; 83(11):1085-1099. PubMed ID: 38479957
[TBL] [Abstract][Full Text] [Related]
8. Diagnosis of cardiac transthyretin amyloidosis based on multimodality imaging.
Dahlem K; Michels G; Kobe C; Bunck AC; Ten Freyhaus H; Pfister R
Clin Res Cardiol; 2017 Jun; 106(6):471-473. PubMed ID: 28303323
[No Abstract] [Full Text] [Related]
9. Unmasking Early Wild-Type Transthyretin Amyloidosis Cardiomyopathy in a Patient With Refractory Atrial Fibrillation and Unremarkable Cardiac Imaging.
Varedi D; Kovacsovics T; Downs Kelly E; Abraham J; Cowley J; Barrell K; Revelo MP; Stehlik J; Drakos S; Marrouche N; Wilson B; Swanson EA; Fang J; Nativi-Nicolau J
Circ Heart Fail; 2018 Jul; 11(7):e004812. PubMed ID: 29921704
[No Abstract] [Full Text] [Related]
10. Cardiac Amyloidosis in a Child Presenting with Syncope: The First Reported Case and a Diagnostic Dilemma.
Torpoco Rivera DM; Williams CT; Karpawich PP
Pediatr Cardiol; 2022 Mar; 43(3):700-703. PubMed ID: 34783874
[TBL] [Abstract][Full Text] [Related]
11. Cardiac Amyloidosis: Overlooked, Underappreciated, and Treatable.
Rubin J; Maurer MS
Annu Rev Med; 2020 Jan; 71():203-219. PubMed ID: 31986086
[TBL] [Abstract][Full Text] [Related]
12. Wild-Type Transthyretin Cardiac Amyloidosis Is Associated with Increased Antecedent Physical Activity.
Lee YZJ; Fajardo J; Brown E; D'Adamo CR; Judge DP
J Cardiovasc Transl Res; 2022 Aug; 15(4):689-691. PubMed ID: 35083733
[No Abstract] [Full Text] [Related]
13. Epidemiology and clinical manifestations of cardiac amyloidosis.
Bajwa F; O'Connor R; Ananthasubramaniam K
Heart Fail Rev; 2022 Sep; 27(5):1471-1484. PubMed ID: 34694575
[TBL] [Abstract][Full Text] [Related]
14. Amyloid Deposits and Fibrosis on Left Ventricular Endomyocardial Biopsy Correlate With Extracellular Volume in Cardiac Amyloidosis.
Pucci A; Aimo A; Musetti V; Barison A; Vergaro G; Genovesi D; Giorgetti A; Masotti S; Arzilli C; Prontera C; Pastormerlo LE; Coceani MA; Ciardetti M; Martini N; Palmieri C; Passino C; Rapezzi C; Emdin M
J Am Heart Assoc; 2021 Oct; 10(20):e020358. PubMed ID: 34622675
[TBL] [Abstract][Full Text] [Related]
15. Diagnosing transthyretin amyloidosis in patients with known genetic cardiomyopathies - opportunities and open questions.
Casian M; Jurcut R
Rev Esp Cardiol (Engl Ed); 2024 Jun; 77(6):504-505. PubMed ID: 38056771
[No Abstract] [Full Text] [Related]
16. Progress and challenges in the treatment of cardiac amyloidosis: a review of the literature.
Adam RD; Coriu D; Jercan A; Bădeliţă S; Popescu BA; Damy T; Jurcuţ R
ESC Heart Fail; 2021 Aug; 8(4):2380-2396. PubMed ID: 34089308
[TBL] [Abstract][Full Text] [Related]
17. Hereditary transthyretin-related amyloidosis is frequent in polyneuropathy and cardiomyopathy of no obvious aetiology.
Skrahina V; Grittner U; Beetz C; Skripuletz T; Juenemann M; Krämer HH; Hahn K; Rieth A; Schaechinger V; Patten M; Tanislav C; Achenbach S; Assmus B; Knebel F; Gingele S; Skrahin A; Hartkamp J; Förster TM; Roesner S; Pereira C; Rolfs A
Ann Med; 2021 Dec; 53(1):1787-1796. PubMed ID: 34658264
[TBL] [Abstract][Full Text] [Related]
18. Diagnosing transthyretin amyloidosis in patients with known genetic cardiomyopathies - opportunities and open questions. Response.
Martín-Álvarez E; Larrañaga-Moreira JM; Crepo-Leiro MG; Barriales-Villa R
Rev Esp Cardiol (Engl Ed); 2024 Jun; 77(6):505-506. PubMed ID: 38237660
[No Abstract] [Full Text] [Related]
19. [Cardiac amyloidosis: State of art in 2022].
Oghina S; Delbarre MA; Poullot E; Belhadj K; Fanen P; Damy T
Rev Med Interne; 2022 Sep; 43(9):537-544. PubMed ID: 35870985
[TBL] [Abstract][Full Text] [Related]
20. Cardiac amyloidosis: an update on diagnosis, current therapy, and future directions.
Khedraki R
Curr Opin Cardiol; 2022 May; 37(3):272-284. PubMed ID: 35612939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
